Isotype profiles of anti-gp160 antibodies from HIV-infected patients in plasma and culture supernatants

被引:4
作者
Béniguel, L
Bégaud, E
Peruchon, S
Cognasse, F
Gabrié, P
Marovich, M
Lucht, F
Genin, C
Garraud, O
机构
[1] Univ St Etienne, Fac Med, GIMAP EA 3064, F-42023 St Etienne, France
[2] Inst Pasteur, Bangui, Cent Afr Republ
[3] Hop Communautaire, Bangui, Cent Afr Republ
[4] CHU St Etienne, Serv Malad Infect, St Etienne, France
[5] Combined US Mil HIV Res Program, Rockville, MD USA
关键词
isotype; IgG3; anti-HIV antibody; high viral load;
D O I
10.1016/j.imlet.2004.02.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We studied isotype profiles of anti-HIV antibodies (Ab) in HIV-1-infected African patients with high viral loads and major B cell dysfunction. We focussed on IgG1, IgG3, and IgA as these classes and subclasses tend to support neutralizing functions against HIV. Total IgG1, IgG3 and IgA were detected in the plasma of both HIV-1-infected and HIV-negative African individuals, but there was significantly more IgG3, a rare subclass, in HIV-1-infected patients (P < 0.05). Anti-HIV-gp160 specific antibodies were detected in sera from nearly all HIV-1-infected individuals tested, but not in HIV- individuals: 10/10, 9/10 and 8/10 individuals displayed specific IgG1, IgG3 and IgA, respectively. In the corresponding PBMC cultures carried out in the presence of IL-10 and IL-2, there was specific IgG1 and IgA in 5110, and 3/10, respectively, but no IgG3 was detected. When HAART-treated European HIV-infected PBMC cultures were tested using the same protocol, specific IgG3 was detected in 4/10 cultures, and was unaffected by the addition of soluble CD40L molecules. The present study thus shows that, despite lymph node disorganization in HIV-infected drug-naive Africans, these individuals retain the ability to produce HIV-specific IgG1, IgG3 and IgA. However, the specific mechanisms controlling the selective production of IgG3, probably the most potent subclass and a potential target of immuno-intervention, warrants further investigation. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:57 / 62
页数:6
相关论文
共 28 条
[1]  
BECK OE, 1981, CLIN EXP IMMUNOL, V43, P626
[2]   Broad spectrum of coreceptor usage and rapid disease progression in HIV-1-infected individuals from Central African Republic [J].
Bégaud, E ;
Feindirongai, G ;
Versmisse, P ;
Ipero, J ;
Léal, J ;
Germani, Y ;
Morvan, J ;
Fleury, H ;
Müller-Trutwin, M ;
Barré-Sinousi, F ;
Pancino, G .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2003, 19 (07) :551-560
[3]   Differential production in vitro of antigen specific IgG1, IgG3 and IgA:: a study in Schistosoma haematobium infected individuals [J].
Béniguel, L ;
Diallo, TO ;
Remoué, F ;
Williams, DL ;
Cognasse, F ;
Charrier-Mze, N ;
N'Diaye, AA ;
Perraut, R ;
Capron, M ;
Riveau, G ;
Garraud, O .
PARASITE IMMUNOLOGY, 2003, 25 (01) :39-44
[4]  
BENIGUEL L, IN PRESS CLIN DEV IM
[5]  
BENIGUEL L, UNPUB
[6]   Compartmentalization of HIV-1 according to antiretroviral therapy: viral loads are correlated in blood and semen but poorly in blood and saliva [J].
Bourlet, T ;
Cazorla, C ;
Berthelot, P ;
Grattard, F ;
Cognasse, F ;
Fresard, A ;
Defontaine, C ;
Lucht, FR ;
Genin, C ;
Pozzetto, B .
AIDS, 2001, 15 (02) :284-285
[7]   INTERLEUKIN-10 AND TRANSFORMING GROWTH-FACTOR-BETA COOPERATE TO INDUCE ANTI-CD40 ACTIVATED NAIVE HUMAN B-CELLS TO SECRETE IMMUNOGLOBULIN-A [J].
DEFRANCE, T ;
VANBERVLIET, B ;
BRIERE, F ;
DURAND, I ;
ROUSSET, F ;
BANCHEREAU, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (03) :671-682
[8]   CYTOKINES IN HIV-INFECTION [J].
EMILIE, D ;
FIOR, R ;
JARROUSSE, B ;
MARFAINGKOKA, A ;
MERRIEN, D ;
DEVERGNE, O ;
CREVON, MC ;
MAILLOT, MC ;
GALANAUD, P .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1994, 16 (5-6) :391-396
[9]   Detection of peripheral HIV-1-specific memory B cells in patients untreated or receiving highly active antiretroviral therapy [J].
Fondere, JM ;
Huguet, MF ;
Yssel, H ;
Baillat, V ;
Reynes, J ;
van de Perre, P ;
Vendrell, JP .
AIDS, 2003, 17 (16) :2323-2330
[10]   Spontaneous secretion of immunoglobulins and anti-HIV-1 antibodies by in vivo activated B lymphocytes from HIV-1-infected subjects:: Monocyte and natural killer cell requirement for in vitro terminal differentiation into plasma cells [J].
Fournier, AM ;
Fondere, JM ;
Alix-Panabieres, C ;
Merle, C ;
Baillat, V ;
Huguet, MF ;
Taïb, J ;
Ohayon, V ;
Zembala, M ;
Reynes, J ;
Vendrell, JP .
CLINICAL IMMUNOLOGY, 2002, 103 (01) :98-109